Vaccitech Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
OXFORD, United Kingdom, Nov. 12, 2021 — Vaccitech plc (NASDAQ: VACC) today announced its financial results for the third quarter, ended September 30, 2021, and provided an overview of the Company’s recent corporate developments. Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer.
